Table 3 Indicators of quality of care for persons with T2DM –processes and intermediate results
Indicators | Baseline Visit (N = 1065) | Follow-up visit within 12 months# (N = 776) | Follow-up visit 12—24 months# (N = 565) | p* |
|---|---|---|---|---|
n (%) | n (%) | n (%) | ||
Process indicators | ||||
 HbA1c testing | 216 (20.3%) | 268 (34.5%) | 364 (64.4%) |  < 0.01 |
 Cholesterol LDL testing | 387 (36.3%) | 229 (29.5%) | 407 (72%) |  < 0.01 |
 Triglycerides testing | 332 (31.2%) | 205 (26.4%) | 363 (64.2%) |  < 0.01 |
 Creatinine testing | 102 (9.6%) | 365 (34.3%) | 496 (46.6%) |  < 0.01 |
 Blood pressure measurement | 1055 (99.1%) | 776 (100%) | 538 (95.2%) | NS |
 Monofilament—foot exam performed | 662 (62.1%) 230 (21.6%) | 666 (85.8%) 278 (35.8%) | 493 (87.2%) 186 (32.9%) |  < 0.01  < 0.01 |
 Eye exam performed | 887 (83.3%) | 722 (93%) | 553 (97.9%) |  < 0.01 |
 Any treatment for diabetes$ | 561/648 | 529/617 | 407/464 | NS |
 Hypertensive# on antihypertensive medication | (86.6%) 162/911 | (85.7%) 194/691 | (87.7%) 158/507 |  < 0.01 |
 Age >  = 40 & <  = 75 years on statins | (17.8%) | (28.1%) | (31.2%) |  |
Intermediate Results | ||||
 Poor metabolic control (HbA1c >  = 8%)# | 109/216 (50.5%) | 121/268 (45.1%) | 177/364 (48.6%) | NS  < 0.01 |
 Uncontrolled blood pressure (> = 140/90 mmHg) # | 499/1055 (47.2%) | 325/776 (41.9%) | 166/538 (30.8%) | |